Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Deligne

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Oncoimmunology|September 14, 2020
A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapyAna Victoria Casadesús, Claire Deligne, Béré Kadjdiatou Diallo, et al.
Nature Communications|November 19, 2017
Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggersLorena Zuliani-Alvarez, Anna M Marzeda, Claire Deligne, et al.
Frontiers in Immunology|February 25, 2026
Novel assays to assess the prevalence and neutralizing potential of anti-IdeS antibodies in healthy humansEmna Hannachi, Amélia Trecco, Victoria Daventure, et al.
Cancer Immunology Research|January 17, 2020
Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage PhenotypeClaire Deligne, Devadarssen Murdamoothoo, Anís N Gammage, et al.
Journal of Thrombosis and Haemostasis : JTH|July 20, 2023
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumabMelissa Bou-Jaoudeh, Angelina Mimoun, Sandrine Delignat, et al.
International Journal of Molecular Sciences|May 13, 2023
Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2Martha Gschwandtner, Anís N Gammage, Claire Deligne, et al.
EMBO Molecular Medicine|May 14, 2021
Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progressionDevadarssen Murdamoothoo, Zhen Sun, Alev Yilmaz, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2019
Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patientsBenoit Milcent, Nathalie Josseaume, Quentin Riller, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 10, 2019
Tenascin-C increases lung metastasis by impacting blood vessel invasionsZhen Sun, Inés Velázquez-Quesada, Devadarssen Murdamoothoo, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Oncoimmunology|September 14, 2020
A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapyAna Victoria Casadesús, Claire Deligne, Béré Kadjdiatou Diallo, et al.
Nature Communications|November 19, 2017
Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggersLorena Zuliani-Alvarez, Anna M Marzeda, Claire Deligne, et al.
Frontiers in Immunology|February 25, 2026
Novel assays to assess the prevalence and neutralizing potential of anti-IdeS antibodies in healthy humansEmna Hannachi, Amélia Trecco, Victoria Daventure, et al.
Cancer Immunology Research|January 17, 2020
Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage PhenotypeClaire Deligne, Devadarssen Murdamoothoo, Anís N Gammage, et al.
Journal of Thrombosis and Haemostasis : JTH|July 20, 2023
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumabMelissa Bou-Jaoudeh, Angelina Mimoun, Sandrine Delignat, et al.
International Journal of Molecular Sciences|May 13, 2023
Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2Martha Gschwandtner, Anís N Gammage, Claire Deligne, et al.
EMBO Molecular Medicine|May 14, 2021
Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progressionDevadarssen Murdamoothoo, Zhen Sun, Alev Yilmaz, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2019
Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patientsBenoit Milcent, Nathalie Josseaume, Quentin Riller, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 10, 2019
Tenascin-C increases lung metastasis by impacting blood vessel invasionsZhen Sun, Inés Velázquez-Quesada, Devadarssen Murdamoothoo, et al.
Pageof 2